Annoroad Gene Technology (Beijing) Co., Ltd.

安诺优达基因科技（北京）股份有限公司

Develops genetic-sequencing-based IVD medical devices and life sciences research services in China, including NIPT and CNV-seq Class III test kits for fetal genetic anomaly detection, the NextSeq 550AR sequencer, and bioinformatics software, sold to hospitals and independent clinical laboratories.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Supplier concentration
• Overlapping customers and suppliers
• Distribution model
• Single product, business line or region
• Government or SOE customers and tenders
• Pricing policy and price changes
• Business changes and acquisitions
• Losses and path to profitability
• Net current liabilities or net liabilities
• Negative operating cash flow
• Working capital: receivables, prepayments and cash cycle
• Goodwill, intangibles and asset impairment
• Preferred shares and fair-value liabilities
• Investments and fair-value assets
• Non-IFRS measures and adjustments
• Related-party transactions and balances
• Material share-based payments